AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD
Sanjeev is currently the Country President for AstraZeneca Malaysia
Sanjeev is currently the Country President for AstraZeneca Malaysia
We are witnessing a steady and sustainable growth in the country as the Q2 revenue from operations increased by 31%
The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
Subscribe To Our Newsletter & Stay Updated